2023-12-17 08:45:00 ET
Building a better proverbial mousetrap isn't always a necessary condition for the success of a business, but doing so can help. Those corporations that break new ground often end up being handsomely rewarded, as are those investors bold enough to hold shares of these companies through thick and thin. So investors looking for stocks that can deliver above-average returns through the next 10 years (which probably describes most investors) might want to consider companies that are innovators in their respective fields.
Two great examples are CRISPR Therapeutics (NASDAQ: CRSP) and Block (NYSE: SQ) . Let's find out why these stocks stand a good chance of turning $1,000 into $3,500 -- amounting to a compound annual growth rate (CAGR) of 13.3% -- in the next decade.
Gene editing refers to a set of revolutionary techniques that allow scientists to modify an organism's DNA. The field originated decades ago, but biotechs specializing in gene editing to target rare genetic diseases have made substantial progress in the past few years. CRISPR Therapeutics is one of them, and the company recently became a commercial-stage biotech.
For further details see:
2 Stocks That Could Turn $1,000 Into $3,500 in 10 Years